In a letter Saturday, Daniel O’Day wrote that the company had already produced 1.5 million doses of the drug, equaling around 140,000 treatment courses. Gilead is one of several companies developing drugs to treat Covid-19.

LEAVE A REPLY

Please enter your comment!
Please enter your name here